|
[1]
|
陈学谦, 金有豫 (2006) 新编药物学. 人民卫生出版社, 北京.
|
|
[2]
|
Lynch, B.A., Lambeng, N., Nocka, K., et al. (2004) The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proceedings of the National Academy of Sciences of the United States of America, 101, 9861-9866.
|
|
[3]
|
Custer, K.L., Austin, N.S., Sullivan, J.M., et al. (2006) Synaptic vesicle protein 2 enhances release probability at quies- cent synapses. Journal of Neuroscience, 26, 1303-1313.
|
|
[4]
|
Cereghino, J.J., Biton, V., Abou-Khalil, B., et al. (2000) Levetiracetam for partial seizures: Results of a double-blind, randomized clinical trial. Neurology, 55, 236-242.
|
|
[5]
|
Glauser, T.A., Ayala, R., Elterman, R.D., et al. (2006) Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures. Neurology, 66, 1654-1660.
|
|
[6]
|
Opp, J., Tuxhorn, I., May, T., et al. (2005) Levetiracetam in children with refractory epilepsy: a multicenter open label study in Germany. Seizure, 14, 476-484.
|
|
[7]
|
Massa, R., de Saint-Martin, A., Careangiu, R., et al. (2001) EEG criteria predictive of complicated evolution in idiopathathic rolandic epilepsy. Neurology, 57, 1071-1079.
|
|
[8]
|
Binnie, C.D. (2001) Cognitive performance, subtle seisure, and the EEG. Epilepsia, 42, S16-S18.
|
|
[9]
|
Motamedi, G. and Meador, K. (2003) Epilepsy and cognition. Epilepsy & Behavior, 4, S25-S38.
|
|
[10]
|
Sabers, A., Moller, A., Dam, M., Smed, A., Arlien-Soborg, P., Buchman, J., et al. (1995) Cognitive function and anticonvulsant therapy: Effect of monotherapy in epilepsy. Acta Neurologica Scandinavica, 92, 19-27.
|
|
[11]
|
Aikiä,M., Kälviäinen, R., Sivenius, J., Halonen, T. and Riekkinen, P.J. (1992) Cognitive effects of ox-car-bazepine and phenytoin monotherapy in newly diagnosed epilepsy: One year follow-up. Epilepsy Research, 11, 199-203.
|
|
[12]
|
Park, S.P., Hwang, Y.H., Kim, J.I., et al. (2002) Cognitive function in epileptic patients treated with oxcar-bazepine: Neuropsychologic test and event related potential. Journal of the Korean Neurological Association, 20, 27-33.
|
|
[13]
|
Salinsky, M.C., Spencer, D.C., Oken, B.S., et al. (2004) Effects of oxcarbazepine and phenytoin on the EEG and cognition in healthy volunteers. Epilepsy Behavior, 5, 894-902.
|
|
[14]
|
Donati, F., Gobbi, G., Campistol, J., Rapatz, G., Daehler, M., Sturm, Y., et al. (2006) Effects of oxcarbazepine on cognitive function in children and adolescents with partial seizures. Neurology, 67, 679-682.
|
|
[15]
|
Donati, F., Gobbi, G., Campistol, J., et al. (2007) The cognitive effects of oxcarbazepine versus carbamazepine or valproate in newly diagnosed children with partial seizures. Seizure, 16, 670-679.
|
|
[16]
|
Mecarelli, O., Vicenzini, E., Pulitano, P., et al. (2004) Clinical, cognitive, and neurophysiologic correlates of short- term treatment with carbamazepine, oxcarbazepine, and levetiracetam in healthy volunteers. Annals of Pharmacotherapy, 38, 1816-1822.
|
|
[17]
|
Meador, K.J., Gevinsm A., Loringm D.W., et al. (2007) Neuropsychological and neurophysiologic effects of carbamazepine and levetiracetam. Neurology, 69, 2076-2084.
|
|
[18]
|
Piazzini, A., Chifari, R., Canevini, M.P., et al. (2006) Levetiracetam: An improvement of attention and of oral fluency in patients with partial epilepsy. Epilepsy Research, 68, 181-188.
|
|
[19]
|
Kim, J., Kondratyev, A. and Gale, K. (2007) Antiepileptic drug-induced neuronal cell death in the immature brain: Effects of carbamazepine, topiramate and levetiracetam as monotherapy vs. polytherapy. Journal of Pharmacology and Experimental Therapeutics, 323, 165-173.
|
|
[20]
|
Lagae, L., Buyse, G. and Ceulemans, B. (2005) Clinical experience with levetiracetam in childhood epilepsy: An add- on and monotherapy trial. Seizure, 14, 66-71.
|